CRISPRMED25: Introducing the next six distinguished speakers | Early bird extended Jan. 10th | Virtual event April 7th...

CRISPRMED25: Introducing the next six distinguished speakers | Early bird extended Jan. 10th | Virtual event April 7th...

𝗖𝗥𝗜𝗦𝗣𝗥𝗠𝗘𝗗𝟮𝟱: 𝗜𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝗶𝗻𝗴 𝗼𝘂𝗿 𝗻𝗲𝘅𝘁 𝘀𝗶𝘅 𝗱𝗶𝘀𝘁𝗶𝗻𝗴𝘂𝗶𝘀𝗵𝗲𝗱 𝘀𝗽𝗲𝗮𝗸𝗲𝗿𝘀!

We are honoured to unveil the latest six distinguished experts joining the speaker line-up for the 2nd CRISPR Medicine Conference in April 2025 in Copenhagen! These renowned researchers will contribute valuable insights to our discussions on the latest advancements in genome editing, cellular therapies, and precision medicine.

𝗦𝗿𝗶𝗻𝗶𝘃𝗮𝘀𝗮𝗻 𝗖𝗵𝗮𝗻𝗱𝗿𝗮𝘀𝗲𝗴𝗮𝗿𝗮𝗻, Professor Emeritus at Johns Hopkins Bloomberg School of Public Health, is a pioneer in genome editing and synthetic biology. His groundbreaking work includes the development of zinc finger nucleases, synthetic yeast chromosomes, and CRISPR-based therapies for genetic diseases.

𝗦𝘂𝗸 𝗦𝗲𝗲 𝗗𝗲 𝗥𝗮𝘃𝗶𝗻, Senior Research Physician and Chief of the Gene Therapy Development Unit at the National Institute of Allergy and Infectious Diseases (NIAID), specialises in developing advanced gene therapy approaches for X-linked severe combined immunodeficiency, chronic granulomatous disease, and other inborn immune disorders.

Özcan Met, Associate Professor and Head of the Cell Therapy Unit at CCIT-DK - National Center for Cancer Immune Therapy of Denmark and DTU HealthTech in Denmark, directs the development and manufacturing of cellular products for clinical trials. With over two decades of research into leveraging the immune system to combat cancer, Özcan has overseen the release of more than 200 cell therapy products and accompanied cutting-edge advancements in personalised cancer therapies.

Marcello Maresca, Senior Director Genome Engineering at AstraZeneca, is a leader in precise genome editing with extensive experience in large multinational pharmaceutical organisations. Renowned for his expertise in molecular and cellular biology, he has significantly advanced pre-clinical drug discovery through innovative approaches.

Tedd Elich, Chief Scientific Officer at Life Edit Therapeutics, leads the company’s gene-editing platform development. With more than 25 years experience in biotech, he co-founded LifeEdit Inc. and GrassRoots Biotechnology (acquired by Monsanto Company) and directed research at Cropsolution, Inc.

Jakob Nilsson, Group Leader at the Danish Cancer Institute, leverages genome-editing technologies such as base-editing screens to explore protein function and cellular mechanisms. His recent innovations include optical pooled screening, broadening the analytical scope of functional genomics.

See our full invited speaker list here


Conference dates!

  • April 7th, 2025 - CRISPRMED25 Virtual Event (April 7th, 3:00 - 6:00 PM CET)
  • April 8th - 11th, 2025 - CRISPRMED25 In-person Scientific Conference (April 8th, 2:00 PM CEST - April 11th, 2:00 PM CET)
  • April 8th, 2025 - Founders´Breakfast (April 8th, 9:00 - 1:00 PM CET)


Important deadlines:

  • Early bird registration deadline (EXTENDED): January 10th (register here)
  • Abstract submission deadline: January 17th (submit abstract here)


View the Preliminary Programme here


CRISPRMED25 Sponsors and Supporters

Welcome to MaxCyte, Inc. and ST PHARM - our 2 new CRISPRMED25 sponsors.

Interested in CRISPRMED25 Sponsorship Package Information ? Please request more details at: Info@crisprmedicineconference.com. We have 3 exhibitor packages available.


Virtual Event - April 7th, 3:00 - 6:00 PM CET

If you can not attend the in-person CRISPRMED25 conference in Copenhagen, April 8-11, 2025, you can register and submit an abstract to the CRISPRMED25 virtual poster session April 7th (3:00 - 6:00 PM CET).

The CRISPRMED25 Virtual Event will include 4-5 selected speakers and a 2 hours virtual poster session.

Register for the virtual event here.

All registrants for the virtual event will get access on-demand to the recordings from the in-person event. All approved abstracts will be included in the CRISPRMED25 Abstract Book (digital).


Founders´Breakfast

Founders' Breakfast is an exclusive event for founders, investors and business development teams, working within the field of CRISPR Medicine. The event will include breakfast from one of the leading bakeries in Denmark, selected talks and 1:1 meetings, with the goal to foster new partnerships and collaborations within this exciting field.

There will only be 75 seats available at the Founders' Breakfast, so make sure to reserve your seat today to secure a seat at this exclusive event.


Who will you meet at CRISPRMED25?

More than 100 tickets are already booked to the largest CRISPR Medicine conference. Here below some of the organisations and companies you will meet in Copenhagen in April.

Register here before January 10th and save 20% on your CRISPRMED25 pass.


Are you a student?

As a student/young researcher, you can register for one of the CRISPRMED25/GenE-HumDi COST Action workshops. The workshops will be facilitated by scientific leaders from the GenE-HumDi consortium. The workshop registration is included in the registration fee and there will only be 30 seats available per workshop.

Early bird registration deadline January 10th (register here).

View testimony from Dr. Colette Rogers

Colette Rogers PhD is a postdoctoral researcher at the University of Minnesota, working on the development of new gene-editing approaches to treat Fanconi anaemia. In this WeDoCRISPR video, she shares her thoughts on the inaugural CRISPR Medicine Conference which was held in Copenhagen in April 2024. Have a listen!

OBS - "Scam Event" CRISPR Medicine Event in Boston 2-3 April, 2025

We have been informed by several CRISPRMED25 speakers and members of our global CMN community about an email invitation regarding a CRISPR Medicine "event" in Boston scheduled for April 2-3, 2025. The subject line of those emails is often:

‘Call for Speakers - CRISPR Medicine 2025’ and the organiser of the event is IQ International PTe. LTD.

Please note that this meeting has nothing to do with CMN or CRISPRMED25 and from the details provided it looks like a "scam" event. So, please be aware of this and take the appropriate actions if you receive this email


To view or add a comment, sign in

Explore topics